(Q53510602)

15 May 2018

title

Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. (English)

1 reference

15 May 2018

main subject

cholangiocarcinoma

0 references

internal medicine

0 references

liver transplantation

1 reference

5

1 reference

15 May 2018

Susanne Keiding

2

object named as

Susanne Keiding

1 reference

15 May 2018

Ole L. Munk

7

object named as

Ole Lajord Munk

1 reference

15 May 2018

author name string

Hanne Prytz

1

1 reference

15 May 2018

Einar Björnsson

3

1 reference

15 May 2018

Ulrika Broomé

4

1 reference

15 May 2018

Maria Castedal

6

1 reference

15 May 2018

Swedish Internal Medicine Liver Club

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 May 2018

published in

Hepatology

1 reference

15 May 2018

volume

44

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

1572-1580

1 reference

15 May 2018

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

cites work

1 reference

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

21 January 2018

1 reference

7 January 2021

Primary sclerosing cholangitis: liver transplantation or biliary surgery

1 reference

7 January 2021

Risk factors in primary sclerosing cholangitis

1 reference

7 January 2021

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

1 reference

7 January 2021

Cholangiocarcinoma complicating primary sclerosing cholangitis

1 reference

7 January 2021

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

7 January 2021

Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation

1 reference

7 January 2021

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

7 January 2021

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

1 reference

7 January 2021

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

7 January 2021

FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.

1 reference

7 January 2021

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma

1 reference

7 January 2021

Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer

1 reference

7 January 2021

FDG PET in the diagnosis of hilar cholangiocarcinoma

1 reference

7 January 2021

Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography

1 reference

7 January 2021

FDG PET of infection and inflammation

1 reference

7 January 2021

Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders

1 reference

7 January 2021

Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling

1 reference

7 January 2021

Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.

1 reference

7 January 2021

Is retransplantation an option for recurrent hepatitis C cirrhosis after liver transplantation?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21433

1 reference

15 May 2018

1 reference

15 May 2018